John Oyler is Chief Executive Officer of BeiGene, Ltd.. Currently has a direct ownership of 0 shares of BGNE, which is worth approximately $0. The most recent transaction as insider was on Mar 07, 2025, when has been sold 58,590 shares (American Depositary Shares) at a price of $250.34 per share, resulting in proceeds of $14,667,420. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

JOHN OYLER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2025
SELL
Open market or private sale
$14,667,420 $250.34 p/Share
58,590 Reduced 100.0%
0 American Depositary Sh...
Mar 07 2025
BUY
Exercise of conversion of derivative security
$380,835 $6.5 p/Share
58,590 Added 50.0%
58,590 American Depositary Sh...
Mar 07 2025
BUY
Exercise of conversion of derivative security
$354,373 $0.5 p/Share
708,747 Added 11.23%
5,600,803 Ordinary Shares
Mar 06 2025
SELL
Open market or private sale
$10,447,592 $260.48 p/Share
40,109 Reduced 100.0%
0 American Depositary Sh...
Mar 06 2025
BUY
Exercise of conversion of derivative security
$260,708 $6.5 p/Share
40,109 Added 50.0%
40,109 American Depositary Sh...
Mar 06 2025
BUY
Exercise of conversion of derivative security
$243,080 $0.5 p/Share
486,161 Added 9.04%
4,892,056 Ordinary Shares
Mar 05 2025
BUY
Grant, award, or other acquisition
-
201,084 Added 4.36%
4,405,895 Ordinary Shares
Mar 03 2025
SELL
Open market or private sale
$24,742,980 $244.98 p/Share
101,000 Reduced 100.0%
0 American Depositary Sh...
Mar 03 2025
BUY
Exercise of conversion of derivative security
$656,500 $6.5 p/Share
101,000 Added 50.0%
101,000 American Depositary Sh...
Mar 03 2025
BUY
Exercise of conversion of derivative security
$610,265 $0.5 p/Share
1,220,531 Added 22.52%
4,199,364 Ordinary Shares
Dec 14 2024
BUY
Exercise of conversion of derivative security
$650,000 $0.5 p/Share
1,300,000 Added 30.38%
2,978,833 Ordinary Shares
Oct 08 2024
SELL
Open market or private sale
$1,437,354 $232.77 p/Share
6,175 Reduced 100.0%
0 American Depositary Sh...
Jun 24 2024
SELL
Open market or private sale
$445,710 $159.81 p/Share
2,789 Reduced 100.0%
0 American Depositary Sh...
Jun 17 2024
SELL
Open market or private sale
$204,037 $159.28 p/Share
1,281 Reduced 100.0%
0 American Depositary Sh...
Jun 05 2024
BUY
Grant, award, or other acquisition
-
490,464 Added 21.3%
1,812,018 Ordinary Shares
Mar 13 2024
SELL
Open market or private sale
$2,218,650 $179.91 p/Share
12,332 Reduced 100.0%
0 American Depositary Sh...
Mar 12 2024
SELL
Open market or private sale
$6,227,650 $165.33 p/Share
37,668 Reduced 75.34%
12,332 American Depositary Sh...
Jun 15 2023
BUY
Grant, award, or other acquisition
-
355,641 Added 15.28%
1,971,554 Ordinary Shares
Jan 10 2023
SELL
Open market or private sale
$1,690,549 $248.72 p/Share
6,797 Reduced 100.0%
0 American Depositary Sh...
Dec 29 2022
SELL
Open market or private sale
$385,722 $224.78 p/Share
1,716 Reduced 100.0%
0 American Depositary Sh...
Dec 28 2022
SELL
Open market or private sale
$82,475 $224.73 p/Share
367 Reduced 100.0%
0 American Depositary Sh...
Dec 27 2022
SELL
Open market or private sale
$251,204 $224.29 p/Share
1,120 Reduced 100.0%
0 American Depositary Sh...
Nov 15 2022
SELL
Open market or private sale
$5,166,250 $206.65 p/Share
25,000 Reduced 100.0%
0 American Depositary Sh...
Jun 22 2022
BUY
Grant, award, or other acquisition
-
334,009 Added 13.89%
2,070,913 Ordinary Shares
Sep 15 2021
SELL
Open market or private sale
$5,574,850 $29.31 p/Share
190,203 Reduced 9.87%
1,736,904 Ordinary Shares
JO

John Oyler

Chief Executive Officer
Camana Bay, Grand Cayman, E9

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Track Activities on BGNE